WHO-UMC IDMP Management and Publish API
0.1.0 - CI Build International flag

WHO-UMC IDMP Management and Publish API, published by Uppsala Monitoring Centre. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Uppsala-Monitoring-Centre/WHO-UMC-IDMP-Service/ and changes regularly. See the Directory of published versions

Example MedicinalProductDefinition: MedicinalProductDefinition (Auro methotrexate)

Generated Narrative: MedicinalProductDefinition 1A0661AE2A40

version: 1; Last updated: 2022-08-02 06:33:39+0000;

Information Source: http://idmp.who-umc.org/fhir

Profile: MedicinalProductDefinition for publication

identifier: http://who-umc.org/idmp/CodeSystem/product/1A0661AE2A40, https://health-products.canada.ca/dpd-bdpp/02182750

type: Medicinal Product

domain: Human use

status: Active

combinedPharmaceuticalDoseForm: TABLETS

classification: 10DD499443FAE493691301348AFDDDF3

Contacts

-TypeContact
*Proposed Marketing Authorization Holder/PersonAuro Pharma Inc

​code: WHODrug DrugCode 00113802216: 00113802216

name

productName: Auro methotrexate

Usages

-CountryJurisdictionLanguage
*CanadaCanadaEnglish

Generated Narrative: Organization #auropharmainc

name: Auro Pharma Inc